BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 9840943)

  • 21. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
    Morris L; Allen KE; La Thangue NB
    Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of proteasomes in T cell activation and proliferation.
    Wang X; Luo H; Chen H; Duguid W; Wu J
    J Immunol; 1998 Jan; 160(2):788-801. PubMed ID: 9551914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells.
    Morris TA; DeLorenzo RJ; Tombes RM
    Exp Cell Res; 1998 May; 240(2):218-27. PubMed ID: 9596994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I.
    Iwanaga R; Ohtani K; Hayashi T; Nakamura M
    Oncogene; 2001 Apr; 20(17):2055-67. PubMed ID: 11360190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein.
    Jones DL; Münger K
    J Virol; 1997 Apr; 71(4):2905-12. PubMed ID: 9060648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphorylation of E2F-1 by cyclin A-cdk2.
    Kitagawa M; Higashi H; Suzuki-Takahashi I; Segawa K; Hanks SK; Taya Y; Nishimura S; Okuyama A
    Oncogene; 1995 Jan; 10(2):229-36. PubMed ID: 7838523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes.
    Nahum A; Hirsch K; Danilenko M; Watts CK; Prall OW; Levy J; Sharoni Y
    Oncogene; 2001 Jun; 20(26):3428-36. PubMed ID: 11423993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinoblastoma protein-overexpressing HL60 cells resistant to 1,25-dihydroxyvitamin D3 display increased CDK2 and CDK6 activity and shortened G1 phase.
    Wang QM; Luo X; Kheir A; Coffman FD; Studzinski GP
    Oncogene; 1998 May; 16(21):2729-37. PubMed ID: 9652739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. UCN-01-mediated G1 arrest in normal but not tumor breast cells is pRb-dependent and p53-independent.
    Chen X; Lowe M; Keyomarsi K
    Oncogene; 1999 Oct; 18(41):5691-702. PubMed ID: 10577141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of the role of G1/S cell cycle mediators in cellular senescence.
    Afshari CA; Vojta PJ; Annab LA; Futreal PA; Willard TB; Barrett JC
    Exp Cell Res; 1993 Dec; 209(2):231-7. PubMed ID: 8262140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of a second human cyclin A that is highly expressed in testis and in several leukemic cell lines.
    Yang R; Morosetti R; Koeffler HP
    Cancer Res; 1997 Mar; 57(5):913-20. PubMed ID: 9041194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer.
    Müller-Tidow C; Metzger R; Kügler K; Diederichs S; Idos G; Thomas M; Dockhorn-Dworniczak B; Schneider PM; Koeffler HP; Berdel WE; Serve H
    Cancer Res; 2001 Jan; 61(2):647-53. PubMed ID: 11212263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus E1A-associated p33 kinase.
    Tsai LH; Harlow E; Meyerson M
    Nature; 1991 Sep; 353(6340):174-7. PubMed ID: 1653904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitors of histone deacetylase arrest cell cycle and induce apoptosis in cervical carcinoma cells circumventing human papillomavirus oncogene expression.
    Finzer P; Kuntzen C; Soto U; zur Hausen H; Rösl F
    Oncogene; 2001 Aug; 20(35):4768-76. PubMed ID: 11521189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclin E2, a novel G1 cyclin that binds Cdk2 and is aberrantly expressed in human cancers.
    Gudas JM; Payton M; Thukral S; Chen E; Bass M; Robinson MO; Coats S
    Mol Cell Biol; 1999 Jan; 19(1):612-22. PubMed ID: 9858585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus oncoproteins alter differentiation-dependent cell cycle exit on suspension in semisolid medium.
    Ruesch MN; Laimins LA
    Virology; 1998 Oct; 250(1):19-29. PubMed ID: 9770416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases.
    Wang Y; Prives C
    Nature; 1995 Jul; 376(6535):88-91. PubMed ID: 7596441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uncoupling between phenotypic senescence and cell cycle arrest in aging p21-deficient fibroblasts.
    Dulić V; Beney GE; Frebourg G; Drullinger LF; Stein GH
    Mol Cell Biol; 2000 Sep; 20(18):6741-54. PubMed ID: 10958672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The differential catalytic activity of alternatively spliced cdk2 alpha and cdk2 beta in the G1/S transition and early S phase.
    Kwon TK; Buchholz MA; Jun DY; Kim YH; Nordin AA
    Exp Cell Res; 1998 Jan; 238(1):128-35. PubMed ID: 9457065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation.
    Clurman BE; Sheaff RJ; Thress K; Groudine M; Roberts JM
    Genes Dev; 1996 Aug; 10(16):1979-90. PubMed ID: 8769642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.